Clinical Trial Update: A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants. [Phase 4]

View source ↗

Summary

A Phase 4 trial in healthy Japanese infants evaluated co-administration of a 7-valent pneumococcal conjugate vaccine with a DTaP vaccine; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 7 (Pneumococcal conjugate vaccine, 7-valent)
• dTap Vaccine (Diphtheria and tetanus toxoids and acellular pertussis vaccine)

Snippet

Sponsor: Pfizer | Conditions: Healthy Subjects | Phase 4 | Status: COMPLETED | Results posted: 2013-02-26